In 2024, Adrian Sarstedt joined the SARSTEDT Supervisory Board, taking over the position of his grandmother Inge Sarstedt, who retired after more than ten years on the board. With his experience as co-founder of a successful start-up, Adrian Sarstedt strengthens the next generation in the family business and now represents SARSTEDT in its third generation.
In 2024, SARSTEDT opened a new administration and distribution centre in Saitama, Japan. With a floor space of 4,400 m², the new location consolidates the previously distributed storage capacities and increases capacity by over 70 per cent. This investment strengthens SARSTEDT's position in the Japanese market and marks an important step in the company's expansion strategy in Asia.
In 2024, SARSTEDT opened a new administration and distribution centre in Saitama, Japan. With a floor space of 4,400 m², the new location consolidates the previously distributed storage capacities and increases capacity by over 70 per cent. This investment strengthens SARSTEDT's position in the Japanese market and marks an important step in the company's expansion strategy in Asia.
Professor Dr Rudolf Valenta was awarded the 2024 Research Award for Biochemical Analysis. This prize, donated by SARSTEDT AG & Co. KG, is endowed with 50,000 euros and awarded every two years by the German Society for Clinical Chemistry and Laboratory Medicine (DGKL).
SARSTEDT celebrated its 25th anniversary in Brazil in 2023. The company has been active in the Brazilian healthcare market since 1998 and has become a leading provider of laboratory and medical technology during this time. In 2019, the production site in Porto Feliz, São Paulo, was put into operation, producing primarily the S-Monovette for the local market.
SARSTEDT Inc., USA, was founded in 1973. Entry into the US market began with sales activities and the rental of a warehouse in Princeton, New Jersey. In 1987, the company moved to its current location with production facilities in Newton, North Carolina. In the years that followed, the company experienced steady growth. A new logistics centre was built in 2012, followed by an expansion of the production area in 2017. Today, SARSTEDT Inc., USA, is one of the leading providers of products and services in the fields of laboratory technology, medical technology and life sciences in the USA.
In the spring of 2022, a photovoltaic system was installed on the roof of the largest production hall in the world, at the Nümbrecht – Rommelsdorf site, and commissioned in the autumn. The plant produces approx. 725,000 kWh of electricity annually with the aid of 2,184 photovoltaic modules. The electricity generated is fed into the company’s own grid, thus allowing SARSTEDT to make a sustainable contribution to resource-saving electricity generation. Additional future photovoltaic projects are being planned.
Construction of the new distribution center in Nümbrecht – Elsenroth began in May. The building will be constructed according to the latest energy efficiency standards and include a high-performance photovoltaic system. Commissioning is planned for mid-2024. A modern electron sterilization system will be connected to the distribution center in a second phase of construction.
The biochemist Prof. Dr. Kai Simons and the analytical chemist Dr. Andrej Shevchenko, as well as the transfusion medicine specialist Prof. Dr. Andreas Greinacher, will receive the research prize for biochemical analysis. The prize – sponsored by SARSTEDT in the amount of 50,000 euros – is usually awarded every two years by the German Society for Clinical Chemistry and Laboratory Medicine [Deutsche Gesellschaft für Klinische Chemie und Laboratoriumsmedizin e.V. (DGKL)].
On 1 May 2021, the SARSTEDT Group celebrated the 60th anniversary of its founding by Walter Sarstedt. We can look back on 60 years of growth and international expansion, fuelled by innovative strength and passion for our products and services.
We owe the story of our success to 60 years of committed cooperation, diligence, reliability, and engagement from our workforce.
To express our gratitude, we used this opportunity to raffle off 30 electric vehicles to our employees worldwide. We will provide the winners with access to electromobility through the cost-neutral use of the vehicles for 24 months. For the company, this measure reflects a contribution to a sustainable and environmentally conscious future, which we consider part of our corporate responsibility.
SARSTEDT becomes majority shareholder of Timedico A/S with 80% of the company shares. The Danish manufacturer of the innovative one-touch blood sample transportation system Tempus600® expands the product range for the entire preanalytical process in hospitals and laboratories.
In April, the foundation stone for the new administration building at the Nümbrecht location was laid. The new building provides a modern working environment for the employees and expands the existing capacity at company headquarters. The expansion will enable the company to improve the services it offers its customers.
As part of its continued expansion in South America, SARSTEDT has opened its new production facility in Porto Feliz, close to the city of São Paulo. In future, the facility will assume a key role in supplying the South America region and will also provide the location for the new headquarters of the Brazilian organisation.
At INJECTA GmbH, the foundation stone was laid for the extension to the company’s existing facilities. In order to facilitate further growth and the procurement of new production machinery, the company is extending its Klingenthal location, adding further office and production space
In addition to the existing sales office in Moscow, a new production, warehouse and administrative building is being constructed in St. Petersburg. SARSTEDT is constructing the new building to respond to a continual rise in demand in the Russian market and in the neighbouring countries.
SARSTEDT has developed a revolutionary box and refill concept for pipette tips. In line with market requirements, the universal solution stands out mainly thanks to its high level of user convenience and optimal reliability, while ensuring resources are preserved to the maximum extent.
Taking into account of the significant growth of the US market, the American production facility has been expanded and modernised and now covers around 10,000 m².
A new $50,000 injection molding machine was presented to Catawba Valley Community College at the opening ceremony in December. The new machine is designed to make the college's training even more practical.
(Pictured, from left: Mr. Peter Rumswinkel, Mr. Jürgen Sarstedt, Dr. Garrett Hinshaw, Mr. Rainer Schuster, Mr. Hans-Günter Klein)
On 24 September 2015 the acquisition of the companies MPL and INJECTA 25 years ago was commemorated with a Customer Day at the MPL premises in Brand-Erbisdorf.
Among the almost 250 guests were a considerable number of long-standing customers, business partners and staff members honouring this special anniversary.
The SARSTEDT Group acquires the direct customer business in the field of lab automation of m-u-t GmbH, Wedel/Germany.
With this acquisition, SARSTEDT strengthens its wide portfolio of pre- and post-analytical solutions on the sector of laboratory automation and expands its market position as a global solution provider in this segment.
The transaction includes the takeover of the production of and global direct sales activities for the HCTS2000 MK2 and MK3 units by the international sales organisation of SARSTEDT AG & Co., as well as the service activities in Germany and the USA.
At our headquarters in Nümbrecht, our technical centre is being expanded, with a new building dedicated to production technologies and the development of new products ready for series production.
This investment ensures and improves the company's culture of innovation and further development, and firmly reinforces our expertise in technology, as well as our commitment towards Germany as our main business site.
Upon the death of the company's founder, Mr Walter Sarstedt, we lost a great and exemplary employer and a highly esteemed man. His dedication for innovation and his personal interest in the well-being of both customers and employees was remarkable. In-recognition of his entrepreneural performance and his social engagement he was awarded the Federal Cross of Merit in 1993. Walter Sarstedt has written a significant part of economic history and has built the SARSTEDT Group to become a leading medical technology enterprise. The company will continue to be run as a family business in the future, with the same entrepreneurial spirit of Walter Sarstedt.
Fifty years of SARSTEDT – a success story
Foreword to the anniversary catalogue:
Fifty years of SARSTEDT
This means fifty years of hard work and reliable collaboration with customers and staff.
From the start, we have endeavoured to meet the needs of our customers. This is not something that can be achieved purely through personal dedication; above all, it requires motivated and engaged employees.
Our success is the result of strong product development, a great range of high-quality production on a national and international level, and our own global sales organisation.
I would like to thank all of our customers for their confidence in Sarstedt and all our employees for their relentless support.
I aim to ensure that we endeavour to deliver high-quality, innovative products to our customers in the future.
Walter Sarstedt
The Bulkloader BL 1200 set a new standard for front end laboratory automation. Unsorted, bulk sample tubes are automatically recognised by the system and put in corresponding racks for further processing.
After the huge previous success of the Sarstedt research prize, which has been awarded a total of six times, the German Association for Clinical Chemistry awarded a prize of 50,000 euros for bioanalytics for the first time. By 2015, this prize sponsored by Sarstedt has been awarded four times – more will follow.
Safety and hygiene for patients and users have always been of paramount importance to the company. In the field of blood sampling, a significant improvement was made in the prevention of needle puncture injuries with the introduction of the Safety-Needle and Safety-Multifly® to the market.
The first step towards expanding into Asia was made with the foundation of the branch in Tokyo, Japan.
Following the takeover of French company Rhodiaval in Besançon in 1990, the newly constructed modern manufacturing site for the production of laboratory products was opened.
The foundation of the first sales branch in Sao Paulo, Brazil, was another milestone reached in the company's successful global expansion.
In the same year, the Microvette® was introduced – an ideal system for capillary blood collection, with two sampling techniques (using the end-to-end capillary or the special rim).
The former sole proprietorship Walter Sarstedt becomes a limited share company (AG). This change takes account of the dynamic development of the company and creates the foundations for the generational succession. Walter Sarstedt's children, Doris and Jürgen Sarstedt, who already held active postions within the company become shareholders and members of the newly formed Supervisory Board.
(Picture: Mrs Doris Sarstedt and Mr Walter Sarstedt)
Pre-analytical laboratory automation systems were developed in order to support our customers in establishing optimal and efficient processes in the medical laboratory.
The main focus is to make the processes of pre-sorting, aliquoting, opening and closing of samples containers safer, more accurate and more efficient.
In order to meet the highest standards in research and diagnostics, Sarstedt developed the Biosphere® quality seal. Clean room conditions, trained personnel in protective clothing as well as optimised production processes are the prerequisites needed to ensure the certified absence of biomolecules.
With the acquisition of the company Disposable Products (dp) – a manufacturer of laboratory and medical devices – in Adelaide, the first production site in Australia as well as the sales organisation for this continent was taken over from dp.
For successful in vitro cultivation of cells, Sarstedt introduced cell culture bottles, dishes and plates made from polystyrene for adherent and suspension cells.
The reunification of Germany opened new doors for the company, which proceeded to take over two former publicly-owned companies in Saxony: MPL in Weigmannsdorf and INJECTA in Klingenthal.
MPL expanded the product portfolio with medical devices, such as urine drainage systems.
INJECTA, as a manufacturer of medical cannulae, needles and precision tubes, also contributed a new product segment.
As a leading producer of consumables for medicinal and scientific use, we seek to develop innovative products and customised solutions. In order to realise this in optimal manner and environment, our dedicated R&D Centre in Rommelsdorf was opened-an investment for a successful future.
The innovative blood sedimentation systems Sedivette® and Sediplus® were developed to ensure considerably more hygienic and convenient working methods for determining blood sedimentation rates.
Central to our history is the company's 25th anniversary, the expansion of the company and the funding of science.
To highlight just one of the events, on the occasion of the company's 25th anniversary, the Sarstedt research prize was awarded for the first time on 4 February 1986. This award, which included 50,000 Deutsche Mark in prize money, was advertised internationally and awarded for significant work in the field of diagnostic methods for the early recognition of diseases. The first prize winners were Prof. J. Klose and Prof. P. H. O'Farrell, who received this award for the development of high-resolution, two-dimensional gel electrophoresis. The Sarstedt research prize has been awarded a total of six times up to 2007.
(Pictured, from left: Prof. P.H. O'Farrell, Mr Walter Sarstedt and Prof. J. Klose)
Foundation stone laid for new head office
The continually strong growth of the company calls for additional capacity. In 1986, Walter Sarstedt and his son Jürgen laid the foundation stone for the new head office in Nümbrecht/Rommelsdorf. Here, Setting the course for the future expansion will take place.
Six years after the introduction of the Luer Monovette®, the S-Monovette® and the corresponding cannulae comprised the first closed all-plastic blood sampling system. Blood collection was revolutionised: for the first time the user could decide between two sampling techniques using the S-Monovette® (vacuum or aspiration principle).
With the development and introduction of screw cap micro tubes, Sarstedt established a new class of safe screw cap tubes. The combination of stable polypropylene tubes and extra-safe screw closure with an O-ring seal has proven its worth time and again. Today, screw cap micro tubes are essential for research and diagnostics.
The first venous blood collection system, the predecessor to today's S-Monovette®, is presented. It is available in three sizes with various preparations.
The laboratory product range is extended to include a diverse range of reaction tubes with attached lids.
